Dr. Harry Bear on Translating Pathological Complete Response to OS Benefits

Video

Bear discusses studies adding treatments to chemotherapy in order to increase the pathological complete response (pCR) rate and the difficulties of translating those benefits into better overall survival (OS) rates for patients with breast cancer.

Harry Bear, MD, PhD, chair, Surgical Oncology, Virginia Commonwealth University Health, discusses studies adding treatments to chemotherapy in order to increase the pathological complete response (pCR) rate and the difficulties of translating those benefits into better overall survival (OS) rates for patients with breast cancer. Bear says in order to impact OS, the treatment a patient is given must greatly impact their pCR.

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Related Content
AI-Powered Pathology Tools May Boost Precision Oncology

AI-Powered Pathology Tools May Boost Precision Oncology

Dylann Cohn-Emery
May 8th 2025
Article

Stuart J. Schnitt, MD, discussed artificial intelligence enhancements roadblocks, and potential integration for cancer diagnostics with Targeted Oncology.

Read More

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Jordyn Sava;Aditya Bardia, MD, MPH
February 6th 2025
Podcast

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan in breast cancer.

Listen

RP1 and the Future of Oncolytic Therapy in Melanoma

RP1 and the Future of Oncolytic Therapy in Melanoma

Jordyn Sava
May 5th 2025
Article

Mohammed Milhem, MBBS discussed the mechanism of action of RP1, the design and preliminary findings of the IGNYTE trial in melanoma.

Read More

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Jordyn Sava;Sanjay K. Juneja, MD
January 15th 2025
Podcast

In this episode of Targeted Talks, Sanjay K. Juneja, MD, discusses the exciting advancements of artificial intelligence in 2024.

Listen

CBT Benefits Cancer Patients' Mental Health and Treatment Adherence

CBT Benefits Cancer Patients' Mental Health and Treatment Adherence

Sabrina Serani
May 2nd 2025
Article

Sofia Chernoff, PsyD, MSEd, discussed how cognitive behavioral therapy helps cancer patients manage emotional challenges by modifying negative thoughts and behaviors.

Read More

Study Indicates Early Resolution of CRS, Neurological Events After Axi-Cel

Study Indicates Early Resolution of CRS, Neurological Events After Axi-Cel

Jordyn Sava
May 1st 2025
Article

Olalekan O Oluwole, MD, MBBS, discussed a study on cytokine release syndrome and neurological events post axicabtagene ciloleucel in large B-cell lymphoma.

Read More